Journal article
Maintenance of asthma control by once‐daily inhaled ciclesonide in adults with persistent asthma
Abstract
BACKGROUND: Inhaled corticosteroids (ICS) are recommended therapy for persistent asthma, although side effects can limit appropriate use. Ciclesonide, a novel ICS, is activated in the lung, thereby reducing systemic activity and side effects. This 12-week, double-blind, randomized, parallel-group, placebo-controlled study evaluated the efficacy and safety of ciclesonide in adults with persistent asthma.
METHODS: After a 2-week baseline period …
Authors
Chapman KR; Patel P; D'Urzo AD; Alexander M; Mehra S; Oedekoven C; Engelstätter R; Boulet L
Journal
Allergy, Vol. 60, No. 3, pp. 330–337
Publisher
Wiley
Publication Date
March 2005
DOI
10.1111/j.1398-9995.2004.00750.x
ISSN
0001-5148